Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 2
1989 2
1990 2
1993 2
1994 2
1995 3
1996 3
1997 4
1998 6
1999 2
2000 14
2001 2
2002 1
2003 1
2004 3
2005 3
2006 5
2007 4
2008 10
2009 20
2010 42
2011 44
2012 59
2013 83
2014 100
2015 106
2016 153
2017 204
2018 214
2019 260
2020 358
2021 481
2022 518
2023 533
2024 731
2025 602

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,130 results

Results by year

Filters applied: . Clear all
Page 1
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. Amin MB, et al. CA Cancer J Clin. 2017 Mar;67(2):93-99. doi: 10.3322/caac.21388. Epub 2017 Jan 17. CA Cancer J Clin. 2017. PMID: 28094848 Free article.
The rapid evolution of knowledge in cancer biology and the discovery and validation of biologic factors that predict cancer outcome and response to treatment with better accuracy have led some cancer experts to question the utility of a TNM-based approach in clinical care …
The rapid evolution of knowledge in cancer biology and the discovery and validation of biologic factors that predict cancer outcome a …
Precision medicine in type 1 diabetes.
Carr ALJ, Evans-Molina C, Oram RA. Carr ALJ, et al. Diabetologia. 2022 Nov;65(11):1854-1866. doi: 10.1007/s00125-022-05778-3. Epub 2022 Aug 22. Diabetologia. 2022. PMID: 35994083 Free PMC article. Review.
In the 100 years since the discovery of insulin, this goal has evolved to include personalised approaches to type 1 diabetes diagnosis, treatment, prevention and prediction. ...In this review, we discuss how these personalised approaches have improved …
In the 100 years since the discovery of insulin, this goal has evolved to include personalised approaches to type 1 diabetes diagnosi …
Unravelling Immunoglobulin G Fc N-Glycosylation: A Dynamic Marker Potentiating Predictive, Preventive and Personalised Medicine.
Russell A, Adua E, Ugrina I, Laws S, Wang W. Russell A, et al. Int J Mol Sci. 2018 Jan 29;19(2):390. doi: 10.3390/ijms19020390. Int J Mol Sci. 2018. PMID: 29382131 Free PMC article. Review.
The immunoglobulin G N-glycome is highly heterogenous; however, it is considered an interphenotype of disease (a link between genetic predisposition and environmental exposure) and so has the potential to be used as a dynamic biomarker from the perspective of predictive, …
The immunoglobulin G N-glycome is highly heterogenous; however, it is considered an interphenotype of disease (a link between genetic predis …
Emerging role of deep learning-based artificial intelligence in tumor pathology.
Jiang Y, Yang M, Wang S, Li X, Sun Y. Jiang Y, et al. Cancer Commun (Lond). 2020 Apr;40(4):154-166. doi: 10.1002/cac2.12012. Epub 2020 Apr 11. Cancer Commun (Lond). 2020. PMID: 32277744 Free PMC article. Review.
The DL-based algorithms have been developed to conduct all kinds of work involved in tumor pathology, including tumor diagnosis, subtyping, grading, staging, and prognostic prediction, as well as the identification of pathological features, biomarkers and genetic changes. …
The DL-based algorithms have been developed to conduct all kinds of work involved in tumor pathology, including tumor diagnosis, subtyping, …
Precision medicine for cardiometabolic disease: a framework for clinical translation.
Franks PW, Cefalu WT, Dennis J, Florez JC, Mathieu C, Morton RW, Ridderstråle M, Sillesen HH, Stehouwer CDA. Franks PW, et al. Lancet Diabetes Endocrinol. 2023 Nov;11(11):822-835. doi: 10.1016/S2213-8587(23)00165-1. Epub 2023 Oct 4. Lancet Diabetes Endocrinol. 2023. PMID: 37804856 Review.
To contextualise precision medicine in both research and clinical settings, and to encourage the successful translation of discovery science into clinical practice, in this Series paper we outline a model (the EPPOS model) that builds on contemporary evidence-based …
To contextualise precision medicine in both research and clinical settings, and to encourage the successful translation of dis …
Targeted Therapy and Personalized Medicine.
Saeed RF, Awan UA, Saeed S, Mumtaz S, Akhtar N, Aslam S. Saeed RF, et al. Cancer Treat Res. 2023;185:177-205. doi: 10.1007/978-3-031-27156-4_10. Cancer Treat Res. 2023. PMID: 37306910
Targeted therapy and personalized medicine are novel emerging disciplines of cancer research intended for treatment and prevention. ...In the treatment of a cancer, personalized medicine entails the use of genetic, immunological, and proteomic profiling to pr …
Targeted therapy and personalized medicine are novel emerging disciplines of cancer research intended for treatment and prevention …
Personalised medicine in asthma: from curative to preventive medicine.
Guilleminault L, Ouksel H, Belleguic C, Le Guen Y, Germaud P, Desfleurs E, Leroyer C, Magnan A. Guilleminault L, et al. Eur Respir Rev. 2017 Jan 3;26(143):160010. doi: 10.1183/16000617.0010-2016. Print 2017 Jan. Eur Respir Rev. 2017. PMID: 28049124 Free PMC article. Review.
This review first describes the various asthma phenotypes, some of which were defined empirically and others through cluster analysis, and then discusses personalisation of the patient's diagnosis and therapy, addressing in particular biological therapies and patient education. T …
This review first describes the various asthma phenotypes, some of which were defined empirically and others through cluster analysis, and t …
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Brunet M, et al. Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640. Ther Drug Monit. 2019. PMID: 31045868 Review.
Future studies should investigate the clinical benefit of time-to-event models to better evaluate biomarkers as predictive of personal response, the risk of rejection, and graft outcome. The Expert Committee concludes that considerable advances in the different fields of t …
Future studies should investigate the clinical benefit of time-to-event models to better evaluate biomarkers as predictive of persona …
Precision medicine in the era of artificial intelligence: implications in chronic disease management.
Subramanian M, Wojtusciszyn A, Favre L, Boughorbel S, Shan J, Letaief KB, Pitteloud N, Chouchane L. Subramanian M, et al. J Transl Med. 2020 Dec 9;18(1):472. doi: 10.1186/s12967-020-02658-5. J Transl Med. 2020. PMID: 33298113 Free PMC article. Review.
New strategies are needed to empower communities worldwide to prevent and treat these diseases. Precision medicine provides a model for the next generation of lifestyle modification. ...AI-powered precision medicine provides clinicians with an o …
New strategies are needed to empower communities worldwide to prevent and treat these diseases. Precision medicine prov …
Comprehensive analysis of mitochondrial dysfunction and necroptosis in intracranial aneurysms from the perspective of predictive, preventative, and personalized medicine.
Chen B, Xie K, Zhang J, Yang L, Zhou H, Zhang L, Peng R. Chen B, et al. Apoptosis. 2023 Oct;28(9-10):1452-1468. doi: 10.1007/s10495-023-01865-x. Epub 2023 Jul 6. Apoptosis. 2023. PMID: 37410216 Free PMC article.
In this study, we aimed to explore whether mitochondrial dysfunction and necroptosis could be identified as valuable starting points for predictive, preventive, and personalized medicine for IAs. The transcriptional profiles of 75 IAs and 37 control sa …
In this study, we aimed to explore whether mitochondrial dysfunction and necroptosis could be identified as valuable starting points for …
4,130 results